Palo Alto, Calif. - Connetics Corp., based here, plans to start clinicaltrials on a new acne drug that some reports say is "cosmetically elegant."
The Weekly Roundup: September 18-22
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management
Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More